[HTML][HTML] Role of Selenium in Pathogenesis and Treatment of the Autoimmune Diseases

E Rahmani, AM Fard, H Baghsheikhi, Z Hosseini… - Kindle, 2022 - preferpub.org
In vitro investigations have revealed that consumption of selenium can considerably
decrease the expression of IFN-g in Th1 cells. A low plasma selenium content has been …

Nail Psoriasis & Nail Lichen Planus: Updates on Diagnosis & Management

JK Hwang, C Grover, M Iorizzo, MG Lebwohl… - Journal of the American …, 2023 - Elsevier
Inflammatory diseases of the nail, including nail psoriasis and nail lichen planus, are
associated with significant disease burden and have a negative impact on quality of life …

Secukinumab for the treatment of psoriasis in pediatrics: patient selection and acceptability

J Narbutt, M Niedźwiedź, A Lesiak, J Ceryn… - Patient preference …, 2023 - Taylor & Francis
Psoriasis (PsO) is a chronic, systemic, immune-mediated inflammatory skin disease affecting
1% to 5% population worldwide. In one-third of patients, the first symptoms of PsO manifest …

Black phosphorus hydrogel inverse opal microneedle patches for psoriasis treatment

M Lu, X Zhang, L Cai, J Gan, J Wang, Y Wang, Y Zhao - Nano Today, 2024 - Elsevier
Microneedle patches (MNs) have demonstrated potentials in transdermal drug delivery for
skin disease therapy. Effort is mainly focused on the improvement of MNs' materials …

Nail lichen planus treatment safety

EN Axler, SR Lipner - Expert Opinion on Drug Safety, 2023 - Taylor & Francis
Lichen planus is a chronic inflammatory disorder that may cause significant nail changes
and impair daily life. Nail lichen planus presents a therapeutic challenge, as the condition is …

Biological therapies for the treatment of psoriasis in pediatrics

M Nikolaishvili, V Di Lernia - Expert Opinion on Biological Therapy, 2023 - Taylor & Francis
Introduction Psoriasis is a multifactorial, immune-mediated condition with predominant skin
involvement. It may develop at any age. In one-third of patients, the first symptoms of …

A Practical Guide to Using Biologics in Pediatric Dermatology

A George, RP Lansang, P Lansang… - Journal of …, 2024 - journals.sagepub.com
Psoriasis, hidradenitis suppurativa (HS), atopic dermatitis (AD), and chronic spontaneous
urticaria (CSU), are common, immune-mediated, chronic, inflammatory skin diseases that …

Secukinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients aged six years and older

PK Krajewski, JC Szepietowski - Expert Review of Clinical …, 2023 - Taylor & Francis
Introduction Psoriasis (PSO) is a chronic, recurrent, inflammatory skin disorder that
significantly influences patients' quality of life. The prevalence of PSO among children varies …

Choosing Systemic Agents for Psoriasis

C Kontzias, R Chandy… - Annals of …, 2024 - journals.sagepub.com
Treatment options for moderate-to-severe psoriasis depend on drug efficacy and safety,
patient preferences, comorbidities, and cost—no drug dominates across all dimensions …

Ab-mtedeep classifier trained with aagan for the identification and classification of alopecia areata

C Saraswathi, B Pushpa - Engineering, Technology & Applied Science …, 2023 - etasr.com
Artificial Intelligence (AI) is widely used in dermatology to analyze trichoscopy imaging and
assess Alopecia Areata (AA) and scalp hair problems. From this viewpoint, the Attention …